Stocks of Cabaletta Bio Inc (NASDAQ:CABA) traded higher last session on Wall Street, up 8.12% to $4.13.
CABA stock price is now 5.82% away from the 50-day moving average and -56.74% away from the 200-day moving average. The market capitalization of the company currently stands at $256.18M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $10, UBS recently initiated with Buy rating for Cabaletta Bio Inc (NASDAQ: CABA). On February 05, 2024, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $36, while ‘William Blair’ rates the stock as ‘Outperform’
In other news, Binder Gwendolyn, insider sold 11,000 shares of the company’s stock on Jan 19 ’24. The stock was sold for $215,439 at an average price of $19.59. Upon completion of the transaction, the insider now directly owns 20,000 shares in the company, valued at $82600.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 19 ’23, Binder Gwendolyn sold 11,000 shares of the business’s stock. A total of $240,789 was realized by selling the stock at an average price of $21.89. This leaves the insider owning 20,000 shares of the company worth $82600.0. A total of 15.37% of the company’s stock is owned by insiders.
During the past 12 months, Cabaletta Bio Inc has had a low of $1.76 and a high of $26.35. As of last week, the company has a debt-to-equity ratio of 0.09, a current ratio of 8.11, and a quick ratio of 8.11. The fifty day moving average price for CABA is $3.9142 and a two-hundred day moving average price translates $9.6453 for the stock.
The latest earnings results from Cabaletta Bio Inc (NASDAQ: CABA) was released for 2024-06-30.
